PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Equipment • Services • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Proton therapy market in Americas • Proton therapy market in EMEA • Proton therapy market in APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Technological advances • Increasing number of clinical trials for indication expansion PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • IBA Worldwide • Hitachi • Mevion Medical Systems • ProTom International • Sumitomo Corporation • Varian Medical Systems PART 15: APPENDIX • List of abbreviations PART 16: EXPLORE TECHNAVIO     Exhibit 01: Global radiation oncology market Exhibit 02: Global radiation oncology market – Segments Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global proton therapy market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global proton therapy market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global proton therapy market – Market share by product 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Global proton therapy market by equipment – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Global proton therapy market by equipment – Year-over-year growth 2018-2022 (%) Exhibit 22: Global proton therapy market by services – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Global proton therapy market by services – Year-over-year growth 2018-2022 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Global proton therapy market – Market share by region 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Proton therapy market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 29: Proton therapy market in Americas – Year-over-year growth 2018-2022 (%) Exhibit 30: Top two countries in Americas Exhibit 31: Proton therapy market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 32: Proton therapy market in EMEA – Year-over-year growth 2018-2022 (%) Exhibit 33: Top two countries in EMEA Exhibit 34: Proton therapy market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 35: Proton therapy market in APAC – Year-over-year growth 2018-2022 (%) Exhibit 36: Top two countries in APAC Exhibit 37: Market opportunity Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: IBA Worldwide – Overview Exhibit 44: IBA Worldwide – Business segments Exhibit 45: IBA Worldwide – Organizational developments Exhibit 46: IBA Worldwide – Geographic focus Exhibit 47: IBA Worldwide – Segment focus Exhibit 48: IBA Worldwide – Key offerings Exhibit 49: IBA Worldwide – Key customers Exhibit 50: Hitachi – Overview Exhibit 51: Hitachi – Business segments Exhibit 52: Hitachi – Organizational developments Exhibit 53: Hitachi – Geographic focus Exhibit 54: Hitachi – Segment focus Exhibit 55: Hitachi – Key offerings Exhibit 56: Hitachi – Key customers Exhibit 57: Mevion Medical Systems – Overview Exhibit 58: Mevion Medical Systems – Product segments Exhibit 59: Mevion Medical Systems – Organizational developments Exhibit 60: Mevion Medical Systems – Key offerings Exhibit 61: Mevion Medical Systems – Key customers Exhibit 62: ProTom International – Overview Exhibit 63: ProTom International – Product segments Exhibit 64: ProTom International – Organizational developments Exhibit 65: ProTom International – Key offerings Exhibit 66: ProTom International – Key customers Exhibit 67: Sumitomo Corporation – Overview Exhibit 68: Sumitomo Corporation – Business segments Exhibit 69: Sumitomo Corporation – Organizational developments Exhibit 70: Sumitomo Corporation – Geographic focus Exhibit 71: Sumitomo Corporation – Segment focus Exhibit 72: Sumitomo Corporation – Key offerings Exhibit 73: Sumitomo Corporation – Key customers Exhibit 74: Varian Medical Systems – Overview Exhibit 75: Varian Medical Systems – Business segments Exhibit 76: Varian Medical Systems – Organizational developments Exhibit 77: Varian Medical Systems – Geographic focus Exhibit 78: Varian Medical Systems – Segment focus Exhibit 79: Varian Medical Systems – Key offerings Exhibit 80: Varian Medical Systems – Key customers  

IBA Worldwide Hitachi Mevion Medical Systems ProTom International Sumitomo Corporation Varian Medical Systems